Home › Companies › SERES THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SERES THERAPEUTICS INC.’s Form 8-K, filed April 8, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of April 4, 2024: 7 items on SERES THERAPEUTICS INC.’s Form 8-K, filed April 8, 2024: 1 approved · 6 passed (calculated).
High dissent: 1 shareholder proposal (63.7% support).
Significant dissent: 2 directors (38.1%, 35.2% against); 1 say-on-pay vote (64.6% support).
Notable dissent: 2 other board items (20.8%, 18.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore SERES THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are SERES THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 8, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Paul R. Biondi | 53,477,829 | -- | -- | 29,111,829 | 21,764,552 | 65% | Passed (calculated) | — |
| Elect Director: Kurt C. Graves | 51,107,660 | -- | -- | 31,481,998 | 21,764,552 | 62% | Passed (calculated) | — |
| 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 | 100,843,550 | 2,910,775 | 599,885 | -- | 0 | 97% | Passed (calculated) | — |
| 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers | 52,923,699 | 29,004,971 | 660,988 | -- | 21,764,552 | 65% | Passed (calculated) | — |
| 4. Approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 240,000,000 to 360,000,000 shares | 81,471,934 | 21,346,140 | 1,536,136 | -- | 0 | 79% | Passed (calculated) | — |
| 5. Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there were not sufficient votes at the time of the Annual Meeting to approve Item 4 | 83,248,729 | 19,390,195 | 1,715,286 | -- | 0 | 81% | Passed (calculated) | — |
| 6. Stockholder proposal on Simple Majority Vote | 52,117,624 | 29,641,877 | 830,157 | -- | 21,764,552 | 64% | Approved | — |
Source: SERES THERAPEUTICS INC., Form 8-K, filed with the SEC on April 8, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
112 asset managers disclosed a vote on at least one SERES THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
62% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kurt C. Graves
SERES THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kurt C. Graves”): 51,107,660 for, 31,481,998 withheld, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 62% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 6,843,861 for, 11,391,511 withheld, 18,442 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,018,248 | 0 | 0 | 10,615,535 | Mixed |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 0 | 0 | 0 | 246,775 | Withhold |
| Equitable | 39,464 | 0 | 0 | 127,660 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 150,000 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 80,000 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 48,917 | Withhold |
| Northern Trust | 0 | 0 | 0 | 43,623 | Withhold |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 18,442 | 0 | Abstain |
| DWS | 0 | 0 | 0 | 15,065 | Withhold |
| Victory Capital | 0 | 0 | 0 | 12,948 | Withhold |
| Principal | 0 | 0 | 0 | 12,159 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 11,365 | Withhold |
| State Street | 0 | 0 | 0 | 8,462 | Withhold |
| Calvert | 0 | 0 | 0 | 8,033 | Withhold |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 3,755 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 3,600 | Withhold |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Paul R. Biondi
SERES THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paul R. Biondi”): 53,477,829 for, 29,111,829 withheld, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 65% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 6,981,326 for, 11,254,046 withheld, 18,442 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,018,248 | 0 | 0 | 10,615,535 | Mixed |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 0 | 0 | 0 | 246,775 | Withhold |
| Equitable | 39,464 | 0 | 0 | 127,660 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 150,000 | Withhold |
| Lincoln Financial | 80,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 48,917 | Withhold |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 18,442 | 0 | Abstain |
| DWS | 0 | 0 | 0 | 15,065 | Withhold |
| Victory Capital | 0 | 0 | 0 | 12,948 | Withhold |
| Principal | 0 | 0 | 0 | 12,159 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 11,365 | Withhold |
| State Street | 8,462 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 8,033 | Withhold |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 3,755 | Withhold |
| PENN SERIES FUNDS INC | 3,600 | 0 | 0 | 0 | For |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 240,000,000 TO 360,000,000.
SERES THERAPEUTICS INC.’s own tally for this item (“4. Approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 240,000,000 to 360,000,000 shares”): 81,471,934 for, 21,346,140 against, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 18,253,814 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,633,783 | 0 | 0 | 0 | For |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 246,775 | 0 | 0 | 0 | For |
| Equitable | 167,124 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 150,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 80,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 48,917 | 0 | 0 | 0 | For |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 18,442 | 0 | 0 | 0 | For |
| DWS | 15,065 | 0 | 0 | 0 | For |
| Victory Capital | 12,948 | 0 | 0 | 0 | For |
| Principal | 12,159 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,365 | 0 | 0 | 0 | For |
| State Street | 8,462 | 0 | 0 | 0 | For |
| Calvert | 8,033 | 0 | 0 | 0 | For |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 3,755 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,600 | 0 | 0 | 0 | For |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE PROPOSAL 4.
SERES THERAPEUTICS INC.’s own tally for this item (“5. Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there were not sufficient votes at the time of the Annual Meeting to approve Item 4”): 83,248,729 for, 19,390,195 against, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 18,159,918 for, 93,896 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,633,783 | 0 | 0 | 0 | For |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 246,775 | 0 | 0 | 0 | For |
| Equitable | 167,124 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 150,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 80,000 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 48,917 | 0 | 0 | 0 | For |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 18,442 | 0 | 0 | 0 | For |
| DWS | 15,065 | 0 | 0 | 0 | For |
| Victory Capital | 12,948 | 0 | 0 | 0 | For |
| Principal | 12,159 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,365 | 0 | 0 | 0 | For |
| State Street | 0 | 8,462 | 0 | 0 | Against |
| Calvert | 8,033 | 0 | 0 | 0 | For |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 3,755 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 3,600 | 0 | 0 | Against |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
Prior year: 99.4% for (June 22, 2023 meeting) ▼ 34.8 pts
Description as filed by funds: Approval, on an advisory (non- binding) basis, of the compensation of our named executive officers.
SERES THERAPEUTICS INC.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 52,923,699 for, 29,004,971 against, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 65% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,030,748 | 10,603,035 | 0 | 0 | Mixed |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 246,775 | 0 | 0 | 0 | For |
| Equitable | 167,124 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 150,000 | 0 | 0 | Against |
| Lincoln Financial | 80,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 48,917 | 0 | 0 | 0 | For |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 18,442 | 0 | 0 | 0 | For |
| DWS | 15,065 | 0 | 0 | 0 | For |
| Victory Capital | 12,948 | 0 | 0 | 0 | For |
| Principal | 12,159 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,365 | 0 | 0 | 0 | For |
| State Street | 8,462 | 0 | 0 | 0 | For |
| Calvert | 0 | 8,033 | 0 | 0 | Against |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 3,755 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,600 | 0 | 0 | 0 | For |
| SEI | 2,300 | 0 | 0 | 0 | For |
Fund voting reports, all 32 managers: 7,492,746 for, 10,761,068 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | 0 | 0 | 0 | For |
| Fidelity | 0 | 18,375,792 | 0 | 0 | Against |
| Hudson Bay Capital Management LP | 4,048,179 | 0 | 0 | 0 | For |
| BlackRock | 2,309,345 | 5,136 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,118,482 | 0 | 0 | 0 | For |
| State Street | 1,043,683 | 130 | 0 | 0 | For |
| Woodline Partners LP | 698,999 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 485,915 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| Handelsbanken Fonder AB | 329,926 | 0 | 0 | 0 | For |
| Point72 | 294,327 | 0 | 0 | 0 | For |
| Graham Capital Management, L.P. | 234,343 | 0 | 0 | 0 | For |
| T. Rowe Price | 202,952 | 0 | 0 | 0 | For |
| DE Shaw | 173,851 | 0 | 0 | 0 | For |
| AllianceBernstein | 127,660 | 0 | 0 | 0 | For |
| Vanguard | 123,034 | 0 | 0 | 0 | For |
| SIT INVESTMENT ASSOCIATES INC | 95,425 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 75,098 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 61,076 | 0 | 0 | 0 | For |
| Crestwood Advisors Group, LLC | 60,433 | 0 | 0 | 0 | For |
| Northern Trust | 52,448 | 149 | 0 | 0 | For |
| EDGEWOOD MANAGEMENT LLC | 50,000 | 0 | 0 | 0 | For |
| Rhumbline | 43,262 | 50 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 40,734 | 0 | 0 | Against |
| JPMorgan | 39,255 | 0 | 0 | 0 | For |
Institutional-manager reports, all 92 managers: 35,506,722 for, 18,455,050 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 99.8% for (June 22, 2023 meeting) ▼ 2.6 pts
Description as filed by funds: Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
SERES THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 100,843,550 for, 2,910,775 against, per its Form 8-K filed April 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 18,095,503 for, 158,311 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,633,783 | 0 | 0 | 0 | For |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 246,775 | 0 | 0 | 0 | For |
| Equitable | 167,124 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 150,000 | 0 | 0 | Against |
| Lincoln Financial | 80,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 48,917 | 0 | 0 | 0 | For |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 18,442 | 0 | 0 | 0 | For |
| DWS | 15,065 | 0 | 0 | 0 | For |
| Victory Capital | 12,948 | 0 | 0 | 0 | For |
| Principal | 12,159 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,365 | 0 | 0 | 0 | For |
| State Street | 8,462 | 0 | 0 | 0 | For |
| Calvert | 0 | 8,033 | 0 | 0 | Against |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 3,755 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,600 | 0 | 0 | 0 | For |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Proposed by: Kenneth Steiner
Combines 3 wordings of this item as funds reported it.
64% Approved · of votes cast
Description as filed by funds: A STOCKHOLDER PROPOSAL ON SIMPLE MAJORITY VOTE, IF PROPERLY PRESENTED.
SERES THERAPEUTICS INC.’s own tally for this item (“6. A stockholder proposal on Simple Majority Vote”): 52,117,624 for, 29,641,877 against — passed, per its Form 8-K filed April 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Item 6 – A stockholder proposal on Simple Majority Vote.”
Support: 64% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 18,253,814 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,633,783 | 0 | 0 | 0 | For |
| Vanguard | 4,073,190 | 0 | 0 | 0 | For |
| BlackRock | 1,168,114 | 0 | 0 | 0 | For |
| Charles Schwab | 390,853 | 0 | 0 | 0 | For |
| SIT MUTUAL FUNDS INC | 246,775 | 0 | 0 | 0 | For |
| Equitable | 167,124 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 150,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 80,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 54,730 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 48,917 | 0 | 0 | 0 | For |
| Northern Trust | 43,623 | 0 | 0 | 0 | For |
| Pacific Life | 34,878 | 0 | 0 | 0 | For |
| Voya | 33,061 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,468 | 0 | 0 | 0 | For |
| John Hancock | 18,442 | 0 | 0 | 0 | For |
| DWS | 15,065 | 0 | 0 | 0 | For |
| Victory Capital | 12,948 | 0 | 0 | 0 | For |
| Principal | 12,159 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,365 | 0 | 0 | 0 | For |
| State Street | 8,462 | 0 | 0 | 0 | For |
| Calvert | 8,033 | 0 | 0 | 0 | For |
| Morgan Stanley | 3,866 | 0 | 0 | 0 | For |
| ProShares | 3,755 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,600 | 0 | 0 | 0 | For |
| SEI | 2,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 151,009,462 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 7.70% |
| 2 | Vanguard | 2.70% |
| 3 | BlackRock | 0.77% |
| 4 | Charles Schwab | 0.26% |
| 5 | SIT MUTUAL FUNDS INC | 0.16% |
| 6 | Equitable | 0.11% |
| 7 | BRIDGEWAY FUNDS INC | 0.10% |
| 8 | Lincoln Financial | 0.05% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.04% |
| 10 | Principal Exchange-Traded Funds | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Flagship Pioneering Inc. | 15.31% |
| 2 | Fidelity | 12.17% |
| 3 | Hudson Bay Capital Management LP | 2.68% |
| 4 | BlackRock | 1.53% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.74% |
| 6 | State Street | 0.69% |
| 7 | Woodline Partners LP | 0.46% |
| 8 | MELLON INVESTMENTS Corp | 0.32% |
| 9 | Charles Schwab | 0.26% |
| 10 | Handelsbanken Fonder AB | 0.22% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with Flagship Pioneering | 23,117,045 | 15.31% | Proxy statement (DEF 14A), proxy filed March 5, 2024 |
| FMR LLC | 19,388,579 | 12.84% | Proxy statement (DEF 14A), proxy filed March 5, 2024 |
| Nestlé S.A. | 7,594,038 | 5.03% | Proxy statement (DEF 14A), proxy filed March 5, 2024 |
| BlackRock, Inc. | 7,339,454 | 4.86% | Proxy statement (DEF 14A), proxy filed March 5, 2024 |
| Eric D. Shaff | 2,633,824 | 1.74% | Proxy statement (DEF 14A), proxy filed March 5, 2024 |
| Geode Capital | 2,132,643 | 1.41% | Form 13F, quarter ended March 31, 2024 |
| State Street | 1,946,363 | 1.29% | Form 13F, quarter ended March 31, 2024 |
| Millennium Management | 1,027,552 | 0.68% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 784,693 | 0.52% | Form 13F, quarter ended March 31, 2024 |
| Charles Schwab | 747,318 | 0.49% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 151,009,462 shares outstanding, as reported by SERES THERAPEUTICS INC. on its Form 10-K dated March 1, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At SERES THERAPEUTICS INC.'s shareholder meeting held April 4, 2024, in the 2023-2024 proxy season, 112 asset managers reported votes on at least one of its 7 ballot items in their SEC Form N-PX filings, covering 865 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory (non- binding) basis, of the compensation of our named executive… — FOR was 65% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SERES THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 8, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SERES THERAPEUTICS INC.’s 10-K dated March 1, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
SERES THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Proxy Votes Now, “SERES THERAPEUTICS (MCRB) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/seres-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.